We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has named Flatiron Health’s Amy Abernethy to succeed Rachel Sherman as principal deputy commissioner of food and drugs, which oversees a wide range of the agency’s regulatory, clinical and scientific programs.....